During the past decade, Hospital Universitario La Moraleja conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario La Moraleja" #1 sponsor was "Pfizer" with 2 trials, followed by "Advanz Pharma" with 1 trials sponsored, "Averitas Pharma, Inc." with 1 trials sponsored, "Consorci Sanitari de l'Alt Penedès i Garraf" with 1 trials sponsored and "Eisai Farmacêutica S.A." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario La Moraleja" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "AMS Advanced Medical Services GmbH" with 1 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "European Regional Development Fund" with 1 trials as a collaborator and "Instituto de Salud Carlos III" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario La Moraleja" are "Bone Metastasis" (1 trials), "Cancer Pain" (1 trials), "Hepatic Insufficiency" (1 trials), "Immunosuppression" (1 trials) and "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials). Many other conditions were trialed in "Hospital Universitario La Moraleja" in a lesser frequency.

Most popular intervention types in "Hospital Universitario La Moraleja" are "Drug" (3 trials), "Biological" (2 trials), "Diagnostic Test" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biparametric MRI +/- prostate biopsy" (1 trials), "Ceftobiprole medocaril" (1 trials), "ExPEC9V" (1 trials), "Motor fluctuations diary" (1 trials) and "Multiparametric MRI +/- prostate biopsy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario La Moraleja" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario La Moraleja". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Universitario La Moraleja, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario La Moraleja, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".